Efficacy of simvastatin in reducing postoperative adhesions after thyroidectomy: an experimental study

Acta Chir Belg. 2017 Apr;117(2):77-83. doi: 10.1080/00015458.2016.1242292. Epub 2016 Oct 13.

Abstract

Background: We aimed to investigate whether simvastatin had any impact on the prevention of adhesion formation after thyroidectomy in a rat model.

Methods: This study was performed in 66 Wistar albino rats randomized into three experimental groups. A right hemithyroidectomy was carried out in all the rats. Simvastatin was administered locally at a dose of 0.5 mg/kg and 0.8 mg/kg. Control rats received a saline solution only. Changes during the 1st week, 1st month and 3rd month were evaluated. Efficacy of the treatment was assessed by using a scoring system.

Results: The severity of adhesions in low-dose simvastatin group was significantly less than the control and high-dose groups during the 1st and 3rd month (p < .05). In addition, adhesions were less in the high dose group during the 3rd month, when compared to the control group (p < .05). Moreover, fibrosis and fibroblast scores, which represent adhesions, were significantly lower in low-dose and high-dose groups at 3rd month, compared to controls (p < .05).

Conclusions: We investigated the influence of simvastatin application on post-thyroidectomy adhesion formation in rats. Whether adhesions, causing technical difficulties during neck redo surgery, can be reduced by the use of simvastatin in human, needs to be studied.

Keywords: Head and neck; endocrine; thyroid surgery.

MeSH terms

  • Animals
  • Biopsy, Needle
  • Disease Models, Animal
  • Humans
  • Immunohistochemistry
  • Injections, Intralesional
  • Male
  • Postoperative Complications / drug therapy
  • Postoperative Complications / physiopathology
  • Random Allocation
  • Rats
  • Rats, Wistar
  • Reference Values
  • Simvastatin / administration & dosage*
  • Statistics, Nonparametric
  • Thyroidectomy / adverse effects*
  • Thyroidectomy / methods
  • Tissue Adhesions / drug therapy*
  • Tissue Adhesions / pathology
  • Treatment Outcome

Substances

  • Simvastatin